Nivolumab associated vasculopathy: A novel mechanism

Adeeb Haroon; James K Parker; Kara Braudis; Emily H Smith

doi:10.1016/j.jdcr.2022.01.016

Nivolumab associated vasculopathy: A novel mechanism

JAAD Case Rep. 2022 Jan 29:22:8-10. doi: 10.1016/j.jdcr.2022.01.016. eCollection 2022 Apr.

Authors

Adeeb Haroon¹, James K Parker¹, Kara Braudis¹, Emily H Smith¹

Affiliation

¹ Department of Dermatology, University of Missouri, Columbia, Missouri.

No abstract available

Keywords: CTLA-4, cytotoxic T-lymphocyte antigen-4; ICI(s), immune checkpoint inhibitor(s); PD-1, programmed cell death protein 1 (PD-1) or its ligand (PD-L1); immune-related adverse event; irAE(s), immune-related adverse event(s); nivolumab; vasculopathy.

Publication types

Case Reports